Diabetes Mellitus

Your patient's A1C is 9.2% despite taking insulin — the problem isn't the medication, it's what happens between doses. Daily management decisions determine whether diabetes stays controlled or spirals.

Daily diabetes management centers on blood glucose monitoring, insulin administration technique, and sick-day rules. Fasting blood glucose target is 80–130 mg/dL; postprandial (1–2 hours after eating) target is less than 180 mg/dL. A1C reflects a 2–3 month average and should be below 7% for most adults. Self-monitoring of blood glucose (SMBG) guides real-time insulin and meal adjustments. Insulin must be stored properly — unopened vials refrigerated, opened vials at room temperature up to 28 days. Injection sites rotate within the same anatomic region (e.g., abdomen) to prevent lipodystrophy, and the abdomen provides the fastest, most consistent absorption. When mixing insulins in one syringe, draw clear (regular) before cloudy (NPH) — 'clear before cloudy.' During illness, the patient never skips insulin even if not eating, because stress hormones drive hyperglycemia. Sick-day rules include checking glucose every 4 hours, maintaining hydration, testing urine for ketones when glucose exceeds 240 mg/dL, and contacting the provider if vomiting persists or ketones are moderate to large.

Key Distinctions

Don't confuse fasting glucose targets (80–130 mg/dL) with random or postprandial targets (<180 mg/dL) — NCLEX questions test which threshold applies to which timing. Students commonly think insulin should be held when a sick patient isn't eating — the opposite is true; illness raises glucose. Rotating injection sites means rotating within one region (different spots on the abdomen), not jumping between abdomen and thigh daily, which causes unpredictable absorption.

Clinical Pearl

Clear before cloudy, never skip insulin when sick, and always rotate within — not between — body regions. These three rules cover the most-missed NCLEX items on daily management.

Pathophysiology

Type 1 diabetes is an autoimmune destruction of pancreatic beta cells, resulting in absolute insulin deficiency. The immune system attacks the islets of Langerhans, leaving the pancreas unable to produce insulin at all. Without exogenous insulin, the patient cannot move glucose into cells and will break down fat for fuel — which is why Type 1 presents acutely, often with DKA as the first sign. Onset is typically in childhood or young adulthood, though it can occur at any age. Autoantibodies (such as GAD65 and islet cell antibodies) confirm the autoimmune process. Type 2 diabetes begins with insulin resistance: cells have functioning insulin receptors but impaired post-receptor intracellular signaling (e.g., reduced GLUT4 translocation) blunts insulin's effect. The pancreas compensates by overproducing insulin (hyperinsulinemia), but over years the beta cells exhaust and insulin production declines — a progressive loss, not a sudden one. Because some insulin is still present, lipolysis is partially suppressed, so Type 2 rarely presents with DKA (though ketosis-prone Type 2 can occur, especially in African American and Hispanic populations). Instead, Type 2 accumulates hyperglycemia gradually and may present with HHS rather than DKA. Risk factors for Type 2 include obesity, sedentary lifestyle, and metabolic syndrome. Type 1 always requires exogenous insulin from diagnosis; Type 2 typically begins with lifestyle modification ± metformin. Diagnosis is confirmed by fasting glucose ≥126 mg/dL, A1C ≥6.5%, or random glucose ≥200 mg/dL with symptoms. C-peptide levels help differentiate: low or absent in Type 1, normal or elevated in early Type 2.

Key Distinctions

Absolute vs. relative insulin deficiency: Type 1 = no insulin production; Type 2 = insulin present but ineffective due to resistance, with progressive decline. | DKA vs. HHS: Type 1 characteristically presents with DKA; Type 2 is more associated with HHS because residual insulin suppresses ketogenesis. | Beta cell burnout: Students assume Type 2 never needs insulin — but progressive beta cell failure eventually requires it. | Age and body habitus don't diagnose type: A thin young adult can have Type 2, and an adult can develop Type 1 (LADA) — autoantibody testing and C-peptide clarify the diagnosis.

Clinical Pearl

Think of Type 1 as an empty gas tank (no insulin made) and Type 2 as a clogged fuel line (insulin is there but can't do its job). C-peptide tells you which one you're dealing with.

Diabetes Screening & Prediabetes

Diabetes screening in the community targets asymptomatic adults to detect prediabetes and type 2 diabetes early, when lifestyle interventions are most effective. The USPSTF recommends screening for adults aged 35-70 who are overweight or obese. The ADA recommends screening for all adults starting at age 35 (previously 45), and earlier for those with risk factors: BMI 25 or higher (23 or higher for Asian Americans), family history of diabetes, history of gestational diabetes, polycystic ovary syndrome, race/ethnicity with higher prevalence (Black, Hispanic, Native American, Asian American, Pacific Islander), hypertension, HDL under 35 or triglycerides over 250, or physical inactivity. Three screening tests are used: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and hemoglobin A1C. Prediabetes is defined as FPG 100-125, OGTT 140-199, or A1C 5.7-6.4%. Diabetes is diagnosed at FPG 126 or higher, OGTT 200 or higher, or A1C 6.5% or higher. Two abnormal results from the same or different tests are required for diagnosis in asymptomatic individuals. The community health nurse's role includes identifying at-risk individuals through risk assessment questionnaires, conducting or facilitating screening at community sites, educating on the Diabetes Prevention Program (DPP) — an evidence-based lifestyle intervention shown to reduce diabetes risk by 58% through modest weight loss (5-7% of body weight) and 150 minutes per week of moderate physical activity. The nurse refers individuals with abnormal results to primary care and provides culturally appropriate dietary education emphasizing whole grains, vegetables, lean proteins, and portion control.

Key Distinctions

Prediabetes is NOT diabetes — it is a reversible state. The community nurse's message to a prediabetic patient is empowerment (you can prevent this), not resignation (you are going to develop diabetes). Students confuse A1C with fasting glucose — A1C reflects average glucose over 2-3 months and does not require fasting, making it convenient for community screening events where fasting cannot be guaranteed. However, FPG, A1C, and OGTT are all accepted screening tests per USPSTF; none is universally preferred. Point-of-care A1C results are useful for screening, but abnormal findings generally require laboratory confirmation before diagnosis. The DPP is a structured lifestyle program, not generic advice to 'eat better and exercise.' Gestational diabetes is a risk factor for future type 2 diabetes — women with a history of GDM should be screened every 1-3 years postpartum.

Clinical Pearl

A1C does not require fasting — that makes it convenient for community events where participants walk in unprepared. One finger stick, no special preparation, and you have three months of glucose history. But remember: FPG and OGTT are equally valid screening options, and abnormal point-of-care results need lab confirmation.

Diabetes Lifestyle Education

Diabetes lifestyle education focuses on the behavioral and self-management skills the patient takes home: medical nutrition therapy, physical activity, sick-day rules, foot care, and psychosocial coping. For nutrition, the plate method is the simplest tool — half the plate non-starchy vegetables, one quarter lean protein, one quarter carbohydrate. Carbohydrate counting (typically 45–60 g per meal for most adults) is the primary strategy that affects postprandial glucose. Consistent carb intake at each meal matters more than eliminating sugar. For exercise, recommend at least 150 minutes per week of moderate-intensity aerobic activity spread over at least 3 days with no more than 2 consecutive days off. The critical teaching point: exercise lowers blood glucose, so the patient must check glucose before activity and carry a fast-acting carbohydrate source. Sick-day rules include never stopping insulin (especially in Type 1), monitoring glucose every 4 hours, checking urine ketones (Type 1), drinking adequate fluids, and contacting the provider if glucose exceeds 300 mg/dL or if the patient cannot keep fluids down. Foot care education — daily inspection, proper footwear, no walking barefoot, cutting nails straight across — prevents the amputations that chronic neuropathy sets up. Annual dilated eye exams and regular dental visits round out the self-care framework.

Key Distinctions

Don't confuse lifestyle education (behavioral teaching YOU provide) with daily management (insulin timing, SMBG technique, medication administration) — this atom is about what the patient does independently at home, not the pharmacologic regimen. Students mix up sick-day rules: the patient should NEVER skip insulin during illness even if not eating. Carbohydrate counting is not the same as calorie counting — the focus is grams of carbohydrate per meal, not total calories.

Clinical Pearl

"Never barefoot, never skip insulin when sick, never exercise without a fast-acting carb in your pocket." Three nevers that prevent three disasters: amputation, DKA, and severe hypoglycemia.

Diabetes Chronic Complications

Chronic hyperglycemia damages blood vessels through two pathways: microvascular (small vessel) and macrovascular (large vessel). Microvascular complications include retinopathy, nephropathy, and neuropathy. Retinopathy is the leading cause of blindness in working-age adults — annual dilated eye exams start at diagnosis for type 2 and within 5 years for type 1. Nephropathy begins as microalbuminuria (urine albumin-to-creatinine ratio ≥30 mg/g), progressing to end-stage renal disease; annual urine albumin screening is essential. Peripheral neuropathy presents as "stocking-glove" numbness, burning, or tingling in the feet first, creating injury risk the patient cannot feel. Macrovascular complications — coronary artery disease, stroke, and peripheral arterial disease — are the leading cause of death in diabetes. Cardiovascular risk is 2-4 times higher than in nondiabetics. A general HbA1c target below 7% slows microvascular progression significantly. Nurses assess feet at every visit: skin integrity, sensation (monofilament testing), pedal pulses, and capillary refill. Poorly healing wounds, especially on feet, can escalate to osteomyelitis and amputation. Autonomic neuropathy causes gastroparesis, orthostatic hypotension, and neurogenic bladder — symptoms students frequently overlook.

Key Distinctions

Don't confuse peripheral neuropathy (sensory loss, burning pain in extremities) with peripheral arterial disease (diminished pulses, claudication, cool extremities) — both affect the feet but through different mechanisms. Students mix up microalbuminuria (early, reversible nephropathy marker) with elevated serum creatinine (late-stage kidney damage). Autonomic neuropathy is not the same as peripheral neuropathy — it affects internal organs, not just hands and feet.

Clinical Pearl

Eyes, kidneys, nerves, feet, heart — screen them all on schedule. The damage that blinds or amputates started years before the patient noticed anything.